MAAT INDEX

CLAIM #19283 · CVX (CVX) · 2025Q4 earnings call · Jan 30, 2026 · due Dec 31, 2026

So we're very confident in the target that we've set and delivering that over the course of this year.

Eimear Bonner · CFO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Cumulative cost reduction savings from the organizational efficiency/cost reduction program, fiscal year 2026

It came true if: Reported annualized/cumulative savings between $3,000,000,000 and $4,000,000,000

Where: Company-disclosed cost savings figures (earnings release / management commentary on Q4 2026 call or 10-K)

In context

ly, kind of lessons learned or areas that are still a work in progress. Eimear Bonner: Okay. Thanks, Devin. Yeah. We've hit the ground running, and we went live with the new organization in October. And, the new operating model is live and well, and, you know, we're seeing that reflected in the early results that we've shown you today in the prepared comments. So we've saved $1,500,000,000 thus far on the cost reduction program. So some of that's coming from divestments. Some of that's coming from efficiencies and technology, and so you see the early results of the organizational impacts in the results already. The run rate's greater than $2,000,000,000. You know, at the end of the year. So, we are expecting the organizational efficiencies to add to the results that we're seeing thus far. So we're very confident in the target that we've set and delivering that over the course of this year. And just a reminder, that's three to four billion dollars. Look. In terms of the lessons learned, what I'd say is we're seeing results everywhere. Every team as part of this program has been benchmarking, has been looking for areas of improvement. So we've got a lot of programs that are looking at improving our competitiveness across every metric. Some of the examples that I would call out, production chemicals, now that we have our shale and tight portfolio and assets altogether in one business, we've been able to look at that from an operational efficiency perspective not only the optimized operationally, know, the chemical treatments, but also the cost, and the dose. So that would be an operational lessons learned, word of the scale, and the design of the new organization makes that ea

Verify independently

SEC filings for CVX · Claim quote is verbatim from the 2025Q4 earnings call.